Drug
Sevelamer
Sevelamer: highest development phase Post-Market, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sevelamer HCl NCT01755078 | Post-Market | Hemodialysis |
Latest
No recent events.
Follow Sevelamer on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.